All In MedTech

Device Trial Radar · NCT05661981

GLYCAR Post Market Multicenter Study

A Post Market Multicenter Clinical Investigation of GLYCAR Bovine Pericardial Patch With EnCap™ Technology in Cardiac and Vascular Repair or Reconstruction Surgery. GLYCAR Study

Last checked: Nov 20, 2026Latest source record: Jun 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

110

Planned (sponsor's estimate)

Start

Oct 9, 2023

Primary completion

Jun 2026

Study completion Jun 2027

Sponsor

Lead sponsor
GLYCAR SA (Pty) LtdNot on our public-company list
Sponsor type
Industry
First posted
Dec 22, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, non-interventional, observational, multi-center, single arm, post market clinical follow-up study

Conditions

  • Congenital Premature Cardiac Closure
  • Cardiac and Great Vessel Reconstruction and Repair
  • Peripheral Vascular Reconstruction and Repair

Interventions

  • GLYCAR Pericardial PatchDevice

    The Glycar patches are intended to be used by surgeons specialized in the field of cardiovascular surgery. The patch is intended to be used for pericardial closure, or repair and/or reconstruction of cardiovascular structures by replacing missing tissue, reinforcing weakened tissue and providing extra strength to repair tissue during healing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Glycar- Pericardial patch related mortalityTime frame: 30 days post procedure or hospital discharge (whichever comes first)

1 more outcomes with a free account

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • Marie Lannelongue Hospital

    Le Plessis-Robinson, France

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.